🇺🇸 FDA
Patent

US 12133924

Compositions and methods for organ specific delivery of nucleic acids

granted A61KA61K31/7105A61K31/713

Quick answer

US patent 12133924 (Compositions and methods for organ specific delivery of nucleic acids) held by The Board of Regents of the University of Texas System expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/7105, A61K31/713, A61K47/6907, A61K47/6929